Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts

Scientific Reports

Volumn 5, Issue , 2015, Pages 8039-

  Yamayoshi, Seiya ^a   Fukuyama, Satoshi ^a,b   Yamada, Shinya ^a   Zhao, Dongming ^a,b   Murakami, Shin ^a   Uraki, Ryuta ^a   Watanabe, Tokiko ^a,b   Tomita, Yuriko ^a,b   Neumann, Gabriele ^c   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PB2 PROTEIN, INFLUENZA VIRUS; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL; BAGG ALBINO MOUSE; BODY WEIGHT; CELL LINE; DOG; FEMALE; GENETICS; HUMAN; INFLUENZA A VIRUS (H7N9); LUNG; MDCK CELL LINE; METABOLISM; MOUSE; NOSE CAVITY; PATHOGENICITY; REPORTER GENE; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; BODY WEIGHT; CELL LINE; DOGS; FEMALE; GENES, REPORTER; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; LUNG; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; NASAL CAVITY; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84922998539     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08039     Document Type: Article

References (26)

1. Kageyama, T. et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 18, 20453 (2013).
2. Shi, J. Z. et al. Isolation and characterization of H7N9 viruses from live poultry markets-Implication of the source of current H7N9 infection in humans. Chin. Sci. Bull. 58, 1857-1863, doi: DOI 10.1007/s11434-013-5873-4 (2013).
3. Liu, Q. et al.Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes and infection/Institut Pasteur 15, 432-439, doi: 10.1016/j.micinf.2013.04.004 (2013).
4. Lam, T. T. et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502, 241-244, doi: 10.1038/nature12515 (2013).
5. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. The New England journal of medicine 368, 1888-1897, doi: 10.1056/NEJMoa1304459 (2013).
6. Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381, 1916-1925, doi: 10.1016/S0140-6736(13)60903-4 (2013).
7. Wu, A. et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell host & microbe 14, 446-452, doi: 10.1016/j.chom.2013.09.001 (2013).
8. Watanabe, T. et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551-555, doi: 10.1038/nature12392 (2013).
9. Zhu, H. et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341, 183-186, doi: 10.1126/science.1239844 (2013).
10. Mok, C. K. et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. mBio 4 doi: 10.1128/mBio.00362-13 (2013).
11. Zhou, J. et al. Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500-503, doi: 10.1038/nature12379 (2013).
12. Belser, J. A. et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556-559, doi: 10.1038/nature12391 (2013).
13. Zhang, Q. et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341, 410-414, doi: 10.1126/science.1240532 (2013).
14. Richard, M. et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501, 560-563, doi: 10.1038/nature12476 (2013).
15. Rogers, G. N. et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304, 76-78 (1983).
16. Yamada, S. et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS pathogens 6, e1001034, doi: 10.1371/journal.ppat.1001034 (2010).
17. Subbarao, E. K., Kawaoka, Y.&Murphy, B. R. Rescue of an influenza A virus wildtype PB2 gene and a mutant derivative bearing a site-specific temperaturesensitive and attenuating mutation. J Virol 67, 7223-7228 (1993).
18. Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102, 18590-18595, doi: 10.1073/pnas.0507415102 (2005).
19. Hatta, M., Gao, P.,Halfmann, P.&Kawaoka, Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842, doi: 10.1126/science.1062882 (2001).
20. Li, Z. et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 79, 12058-12064, doi: 10.1128/JVI.79.18.12058-12064.2005 (2005).
21. Mok, C. K. et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol 88, 3568-3576, doi: 10.1128/JVI.02740-13 (2014).
22. Yamayoshi, S. et al. Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. J Virol 88, 3127-3134, doi: 10.1128/JVI.03155-13 (2014).
23. Miotto, O. et al. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PloS one 5, e9025, doi: 10.1371/journal.pone.0009025 (2010).
24. Zhang, H. et al. The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. The Journal of general virology 95, 779-786, doi: 10.1099/vir.0.061721-0 (2014).
25. Chen, H. et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 383, 714-721, doi: 10.1016/S0140-6736(14)60111-2 (2014).
26. Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96, 9345-9350, doi:10.1073/pnas.96.16.9345 (1999).